Literature DB >> 1347364

Flucloxacillin jaundice.

C K Fairley, I Boyd, P Purcell, J McNeil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1347364     DOI： 10.1016/0140-6736(92)90837-s

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Bone and joint infections in the elderly: practical treatment guidelines.

Authors:  J T Mader; M E Shirtliff; S Bergquist; J H Calhoun
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 2.  Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?

Authors:  B M Devereaux; D H Crawford; P Purcell; L W Powell; H P Roeser
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Severe jaundice in two infants with cystic fibrosis.

Authors:  F E Smith; I M Doughty; T J David; V Miller; L Patel
Journal:  J R Soc Med       Date:  1996-05       Impact factor: 18.000

4.  Risk factors for development of flucloxacillin associated jaundice.

Authors:  C K Fairley; J J McNeil; P Desmond; R Smallwood; H Young; A Forbes; P Purcell; I Boyd
Journal:  BMJ       Date:  1993-01-23

Review 5.  Acute septic arthritis.

Authors:  Mark E Shirtliff; Jon T Mader
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.